£120k
1 period on recordActive16010654Private limited companySidcup
BELLO CLINICAL RESEARCH LTD
Significant control: Ibrahim Bello (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Bello Clinical Research Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Bello Clinical Research Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
BELLO CLINICAL RESEARCH LTD is an active private limited company (company number 16010654) incorporated on 10 October 2024, registered in Sidcup. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 October 2025, showing net assets of £120k and cash of £177k, with 0 employees on average.
Peer position · net assets
By net assets it sits in the top quarter of 151 comparable companies in Greater London (median £200, upper quartile £53k).
02
Ownership and control
- Mr Ibrahim Bello
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 10 October 20242 yrs ago
- Next accounts due
- 31 July 2027in 276 days
- Confirmation statement due
- 24 October 2027in 361 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£177k
1 period on recordNot reported
0
1 period on record| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 October 2025 | £120k | £177k | — | — | — | — | 0 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £119,796 at 31 October 2025
- Cash at bank of £50,000 or moreCash £176,814
- Incorporated two to five years agoIncorporated 10 October 2024
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 361 days
- Next accounts duein 276 days
- Accounts period endNet assets £120k · small accounts
- Incorporated
08
Similar companies in Greater London
- IDASONIC NANOCOATING TECHNOLOGIES LIMITEDHarrow · inc. Sept 2024
- BOSS UHEALTH BIOSCIENCE ACADEMYBeckenham · inc. Nov 2024
- GB GREEN TECH LIMITEDBeckenham · inc. Sept 2024
- ZAW CONSULTANCY LIMITEDChorleywood · inc. Nov 2024
- OXFORD BIOTECH LIMITEDWembley · inc. Dec 2024
- MYNR TECH LTDCroyley Green · inc. Dec 2024
All companies incorporated on 10 October 2024 · in Oct 2024.
09
Reminders for BELLO CLINICAL RESEARCH LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.